Why the study?
What demographic, clinical, and genetic factors are associated with clopidogrel resistance in subjects receiving clopidogrel?
Population
280 subjects receiving clopidogrel
Comparison
Clopidogrel vs Responders to clopidogrel therapy
Design
Cohort
Authors
Loading...
Clinical factors may flag clopidogrel resistance risk; leaves open whether these genetic polymorphisms meaningfully contribute.
What demographic, clinical, and genetic factors are associated with clopidogrel resistance in subjects receiving clopidogrel?
Clinical and demographic factors such as female sex, advanced age, obesity, and higher platelet count, but not specific genetic polymorphisms, are associated with clopidogrel resistance.
Al‐Husein et al. (2018) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: